Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Drug delivery

January 14, 2021 Drug delivery / Pharma applications

Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of SBECD-enabled Ganaxolone in CDKL5 Deficiency Disorder (CDD)

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders,

Continue reading

January 12, 2021 Drug delivery / Pharma applications

Dendrimer-based formulation of remdesivir

Current formulations of remdesivir are required to be administered intravenously due to the drug’s low solubility, with each infusion taking

Continue reading

January 11, 2021 CD as API / Drug delivery / In Hungarian / Pharma applications

Targetrin Therapeutics, a Cyclolab és EpiPharma új közös vállalata ciklodextrin-peptid konjugátumok fejlesztésére és értékesítésére

A Cyclolab, a ciklodextrin-kutatás, -fejlesztés és -gyártás nagy múltú, világszerte ismert központja valamint az EpiPharma, bio-gyógyszerészeti szolgáltató és peptidegyógyszereket fejlesztő

Continue reading

January 11, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs

Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development

Continue reading

January 11, 2021 Drug delivery / Pharma applications

Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

Sedor Pharmaceuticals, LLC (Sedor) announced on November 9, 2020 that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT

Continue reading

January 7, 2021 Drug delivery / Pharma applications

Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters

Currently, remdesivir is only available as a lyophilized powder for reconstitution and intravenous53 infusion and concentrate solution for dilution and

Continue reading

January 5, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Special Issue “Pharmaceutical and Biomedical Applications of Cyclodextrins and Derivatives”

This Special Issue in Pharmaceutics will collect the latest innovative researches in the field of pharmaceutical and biomedical applications of

Continue reading

December 29, 2020 Drug delivery / Environmental / Food / Pharma applications

Covering soy polysaccharides gel on the surface of β-cyclodextrin-based metal–organic frameworks

In this study, β-cyclodextrin-based metal–organic frameworks (β-CDMOFs) were successfully prepared using alkaline potassium ions through a hydrothermal method. Based on post-synthesis

Continue reading

December 28, 2020 CD derivatives / Drug delivery / Other industrial use / Pharma applications

“Perspectives of Cyclodextrins” special issue

The special issue on “Perspectives of Cyclodextrins” has been published. Guest Editor(s): Susana Santos Braga. https://www.mdpi.com/journal/biomolecules/special_issues/cyclodextrins All articles can be

Continue reading

December 22, 2020 Agriculture / Drug delivery / Food / Non-pharma applications / Pharma applications

Encapsulation of Active Molecules and Their Delivery System (Book)

Encapsulation of Active Molecules and Their Delivery System covers the key methods of preparation of encapsulation, as well as release

Continue reading

Posts pagination

«Previous Posts 1 … 63 64 65 66 67 … 82 Next Posts»

Recent Posts

  • Scientific Program of ICS22 India
  • Cyclodextrins may help a therapeutic agent en route to the brain
  • Enhancing Foamability of Oat Milk with In Situ Generated Cyclodextrins
  • 1-Methylcyclopropene: from the CD cavity to the apple tree
  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (435)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (819)
  • E-ducation (63)
  • Environmental (144)
  • Events (242)
  • Food (236)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (419)
  • Other industrial use (113)
  • Pharma applications (1,223)
  • Supramolecular systems (44)
  • Uncategorized (169)

Top Posts

  • Sulfated β-Cyclodextrin-Mediated Antimicrobial Peptide Nanoparticles for Alkaloid Encapsulation
  • Scientific Program of ICS22 India
  • Enhancing Foamability of Oat Milk with In Situ Generated Cyclodextrins
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • Lanosterol eye drops for cataract treatment
  • α-cyclodextrin-based polyrotaxanes for tissue engineering
  • Three generations of thiolated cyclodextrins: A direct comparison of their mucus permeating and mucoadhesive properties
  • Quasi-regular polymeric network of cross-linked sulfobutyl ether derivative of β-cyclodextrin synthesized with moxifloxacin as a template
  • Cyclodextrins in 3D and 4D printing
  • Ronald C.D. Breslow (1931–2017)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...